Corey S Cutler

Corey S Cutler

UNVERIFIED PROFILE

Are you Corey S Cutler?   Register this Author

Register author
Corey S Cutler

Corey S Cutler

Publications by authors named "Corey S Cutler"

Are you Corey S Cutler?   Register this Author

97Publications

3595Reads

15Profile Views

Disability Related to Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2019 Oct 24. Epub 2019 Oct 24.

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.10.019DOI Listing
October 2019

Endogenous thrombopoietin levels are elevated following double cord blood unit transplantation.

Bone Marrow Transplant 2019 Aug 28. Epub 2019 Aug 28.

Division of Hematology, Massachusetts General Hospital, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0652-8DOI Listing
August 2019

Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.

Biol Blood Marrow Transplant 2018 02 12;24(2):393-399. Epub 2017 Oct 12.

Division of Hematology/Oncology, Vanderbilt University, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767523PMC
February 2018

Mechanistic approaches for the prevention and treatment of chronic GVHD.

Blood 2017 01 7;129(1):22-29. Epub 2016 Nov 7.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/early/2016/11/07/blood-2
Web Search
http://dx.doi.org/10.1182/blood-2016-08-686659DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216263PMC
January 2017

A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation.

Haematologica 2016 10 27;101(10):1251-1259. Epub 2016 Jun 27.

Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.141176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046655PMC
October 2016

A novel TERC CR4/CR5 domain mutation causes telomere disease via decreased TERT binding.

Blood 2016 10 1;128(16):2089-2092. Epub 2016 Sep 1.

Division of Hematology/Oncology and Stem Cell Program, Boston Children's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-04-710160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073186PMC
October 2016

Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-Analysis.

Am J Hematol 2016 06 13;91(6):551-5. Epub 2016 Apr 13.

Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24342DOI Listing
June 2016

Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years.

Biol Blood Marrow Transplant 2016 May 31;22(5):910-8. Epub 2015 Dec 31.

Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.12.024DOI Listing
May 2016

Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.

Blood 2016 Feb 15;127(5):646-57. Epub 2015 Dec 15.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-10-672345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742552PMC
February 2016

Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.

Oral Oncol 2015 Oct 12;51(10):944-9. Epub 2015 Aug 12.

Brigham and Women's Hospital, Division of Oral Medicine and Dentistry, 1620 Tremont Street, Suite BC-3-028, Boston, MA 02120, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13688375150028
Publisher Site
http://dx.doi.org/10.1016/j.oraloncology.2015.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727395PMC
October 2015

Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease.

Biol Blood Marrow Transplant 2015 Mar 5;21(3):503-8. Epub 2014 Dec 5.

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, and Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.11.680DOI Listing
March 2015

BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation.

Transpl Immunol 2015 Mar 20;32(2):116-20. Epub 2014 Dec 20.

Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, MA, USA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Division of Neurovirology, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trim.2014.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368450PMC
March 2015

A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.

Biol Blood Marrow Transplant 2014 Nov 10;20(11):1737-43. Epub 2014 Jul 10.

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.06.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465759PMC
November 2014

Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.

J Clin Oncol 2014 Sep 4;32(25):2691-8. Epub 2014 Aug 4.

Rafael Bejar and Bennett Caughey, University of California at San Diego, La Jolla, CA; Kristen E. Stevenson, R. Coleman Lindsley, Brenton G. Mar, David P. Steensma, Jerome Ritz, Robert Soiffer, Joseph H. Antin, Edwin Alyea, Philippe Armand, Vincent Ho, John Koreth, Donna Neuberg, and Corey S. Cutler, Dana-Farber Cancer Institute; R. Coleman Lindsley and Benjamin L. Ebert, Brigham and Women's Hospital, Harvard Medical School, Boston; Petar Stojanov, Gad Getz, and Benjamin L. Ebert, Broad Institute, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.3381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207878PMC
September 2014

Expression of CD30 in patients with acute graft-versus-host disease.

Blood 2012 Jul 1;120(3):691-6. Epub 2012 Jun 1.

Department of Hematology/Oncology, Bone Marrow Transplantation Unit, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-03-415422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401221PMC
July 2012

Cord colitis syndrome in cord-blood stem-cell transplantation.

N Engl J Med 2011 Sep;365(9):815-24

Department of Medicine, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1104959DOI Listing
September 2011

Rituximab for prevention and treatment of graft-versus-host disease.

Int J Hematol 2011 May 7;93(5):578-585. Epub 2011 May 7.

Division of Hematological Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-011-0855-2DOI Listing
May 2011

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

Blood 2009 Apr 23;113(16):3865-74. Epub 2009 Jan 23.

Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-09-177840DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670799PMC
April 2009

Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care.

Arch Surg 2008 Nov;143(11):1041-5; discussion 1046

Department of Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.143.11.1041DOI Listing
November 2008

Case records of the Massachusetts General Hospital. Case 38-2007. A 44-year-old woman with generalized, painful, ulcerated skin lesions.

N Engl J Med 2007 Dec;357(24):2496-505

Department of Dermatology, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcpc0706687DOI Listing
December 2007

High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.

Clin Cancer Res 2007 Oct;13(20):6107-14

Division of Hematologic Malignancies and Department of Medical Oncolog, Dana-Farber Cancer Institute and Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-07-1290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941091PMC
October 2007

Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.

Biol Blood Marrow Transplant 2007 Jun 21;13(6):655-64. Epub 2007 Mar 21.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.01.079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743535PMC
June 2007

Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2006 May;12(5):552-9

Division of Infectious Diseases, Brigham & Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2005.12.032DOI Listing
May 2006